6 articles for “colistin”

Set a search alert

Research ArticleOpen accessEvery word in the titleColistin Resistance among Gram Negative Organisms; an Evolving Problem from Tertiary Care Hospital, Pakistan 2014Tuba Bashir, Altaf AhmedThis Study was design to report the evolving Colistin Resistant Gram Negative Organisms from Pakistan in 2014. From 885 isolates of hospitalized patients, 03 Colistin resistant isolates were reported, 02 were Escherichia coli and 01 was Acinetobacter specie. Colistin of all three isolates was tested by Disk diffusion method, MIC by Phoenix 100 (BD) and E-strip. This report contributes a … …Current Research in Microbiology, Vol. 7, Issue 1 · 15 Mar 2016 · 14,722 accessesView PDF Cite

Research ArticleOpen accessIn the keywordsAntibiotic Sensitivity Pattern of Blood Isolates of Acinetobacter Species in a Tertiary Care Hospital: A Retrospective AnalysisP. S. Shareek, D. Sureshkumar, Ramgopalakrishnan et al.Problem statement: Multi-drug resistant Acinetobacter bacterium is one of the major causes of sepsis in ICUs in tertiary care hospitals in India. In this report we describe the antibiotic sensitivity patterns of Acinetobacter species isolated from blood over a one year period at a tertiary care hospital. Approach: We retrospectively analyzed the sensitivity pattern of Acinetobacter species isolated from blood … …American Journal of Infectious Diseases, Vol. 8, Issue 1 · 24 Mar 2012 · 8,564 accessesView PDF Cite

Research ArticleOpen accessIn the abstractImpact of Multiplex PCR Panel on Reducing Broad-Spectrum Antibiotic Use in Ventilator-Associated PneumoniaMaría Inés Staneloni, Emilio F. Huaier Arriazu et al.The extended use of broad-spectrum antimicrobials contribute to the growing threat of antimicrobial resistance. This study evaluated the impact of a multimodal strategy aiming at reducing the duration of broad-spectrum antimicrobial therapy in Ventilator-Associated Pneumonia (VAP). Conducted in a single Intensive Care Unit (ICU), this quasi-experimental, retrospective study compares a pre-intervention period (08/01/2018-07/01/2019) with an intervention period (08/01/2022-07/01/2023). Adult patients … …American Journal of Infectious Diseases, Vol. 21, Issue 1 · 8 Jul 2025 · 6,582 accessesView PDF Cite

Research ArticleOpen accessIn the abstractImplementation of Antimicrobial Stewardship Program During COVID-19 Era: Cost Effectiveness and Mortality RatesSafaa Alkhiami, Anass Qasem, Hussein Mohamed Hussein, Ali AbdallaThe growing spread of antimicrobial resistance is a major problem on a global level that has provoked several health and government organizations to call for action to counteract the problem. The frequent misuse of antibiotics is prevalent within hospital settings, especially during the COVID-19 era. The introduction of antibiotic stewardship initiatives has demonstrated the capability to decrease both unwarranted antibiotic … …American Journal of Infectious Diseases, Vol. 19, Issue 4 · 30 Jan 2024 · 6,287 accessesView PDF Cite

Review ArticleOpen accessIn the abstractAntimicrobial Resistance Pattern of Pseudomonas aeruginosa from Different Clinical Specimens: Survey ArticleHosniyeh E. Ladadweh, Hiba H. Falana, Jannat M. Ma’ali et al.Pseudomonas aeruginosa (P.A.) is a gram-negative, aerobic rod bacterium that mainly grows in soil and watery environments, infrequently being a part of microflora in healthy individuals. Since P.A. favors the growth in moistened areas, it can colonize in any simple aqueous solution, which in turn raises the risk of contamination and infection in hospital settings. The emergence of drug resistant … …American Journal of Pharmacology and Toxicology, Vol. 16, Issue 1 · 11 Jan 2021 · 8,396 accessesView PDF Cite

Research ArticleOpen accessIn the abstractIn Vitro Activity of Tigecycline in the Era of NDM-1Dorairajan Sureshkumar, Ram Gopalakrishnan, M.A. ThirunarayanIn the current era of New Delhi Metallo-betalactamase-1 (NDM-1) infections and a dry antibiotic pipeline, managing infections caused by Multi-Drug Resistant Gram-Negative Bacterial infections (MDR-GNBs) presents a great challenge to physicians in the developing world. Tigecycline, a broad spectrum glycylcycline is a one among the few treatment options against MDR-GNBs. However it has been studied mostly in the western world, … …Current Research in Microbiology, Vol. 3, Issue 2 · 12 Sep 2012 · 7,493 accessesView PDF Cite